These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13049720)

  • 1. The effect of splenectomy on the action of dicumarol; an experimental study, with case report.
    POSTHUMA AE
    Med Bull (Ann Arbor); 1953 Mar; 19(3):62-9. PubMed ID: 13049720
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.
    MAYER GA; CONNELL WF
    J Am Med Assoc; 1956 Jun; 161(9):806-11. PubMed ID: 13319011
    [No Abstract]   [Full Text] [Related]  

  • 4. [Control of dicoumarin effect on blood coagulation].
    THIES HA
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1952-1953; 273():320-2. PubMed ID: 13045631
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S
    Policlinico Chir; 1956; 63(3):141-59. PubMed ID: 13349502
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T; LUND E; DAM H; SØNDERGAARD E
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type].
    TRONNBERG G
    Nord Med; 1955 Jun; 53(26):1028-9. PubMed ID: 13244879
    [No Abstract]   [Full Text] [Related]  

  • 8. Dilution curves and accuracy in prothrombin estimations during hepatitis and dicumarol therapy.
    MULLERTZ S
    Scand J Clin Lab Invest; 1953; 5(2):179-87. PubMed ID: 13089547
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of two methods for determining prothrombin during dicumarol therapy.
    BEGTRUP H
    Acta Med Scand; 1954; 150(1):11-6. PubMed ID: 13196956
    [No Abstract]   [Full Text] [Related]  

  • 10. The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test.
    MANCHESTER B; RABKIN B
    Circulation; 1954 Nov; 10(5):691-8. PubMed ID: 13209750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects on mother and infant of dicumarol therapy in pregnancy].
    VAN ASSEN FJ; KOOY HJ
    Ned Tijdschr Geneeskd; 1955 Jan; 99(2):107-11. PubMed ID: 14356260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Control of dicumarol therapy; relation between Quick's method and the P and P method of Owren and Aas].
    BIANCO S; CROLLE G
    Minerva Med; 1956 May; 47(39):1486-9. PubMed ID: 13334118
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of dicumarol in the human being on plasma prothrombin time and total prothrombin time.
    QUICK AJ; HUSSEY CV; KASER M
    Am Heart J; 1952 Jul; 44(1):119-23. PubMed ID: 14933315
    [No Abstract]   [Full Text] [Related]  

  • 14. The control of prothrombin activity with tromexan therapy.
    WEINER M; SIMSON G; BURNS JJ; STEELE JM; BRODIE BB
    Am J Med; 1953 Jun; 14(6):689-93. PubMed ID: 13057878
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
    SERT AS
    Tip Fak Mecm; 1954; 17(3):434-9. PubMed ID: 13226361
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
    HOLYOKE JB; WHEELWRIGHT HJ
    N Engl J Med; 1952 Jan; 246(1):15-7. PubMed ID: 14882481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].
    JURGENS R
    Schweiz Med Wochenschr; 1953 May; 83(20):471-5. PubMed ID: 13076081
    [No Abstract]   [Full Text] [Related]  

  • 18. The reduction of autoprothrombin. II. Activity with dicumarol.
    JOHNSON SA; SEEGERS WH
    Circ Res; 1956 Mar; 4(2):182-6. PubMed ID: 13293818
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dicumarol treatment in general practice].
    SCHWAN W
    Ther Ggw; 1952 Oct; 91(10):370-1. PubMed ID: 13029065
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravenous administration of marcoumar].
    DEUTSCH E
    Wien Klin Wochenschr; 1956 Jul; 68(27):553-5. PubMed ID: 13353090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.